Telehealth & Digital Health

A landmark partnership brings a vital IT resilience solution to Europe, aiming to keep patient data accessible and clinicians empowered when systems fail.

With over $10M in new funding, Berlin Heals is advancing a novel implant that uses a gentle electrical field to potentially reverse heart failure damage.

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

Hoag becomes the world's first Center of Excellence in Oncoplastic Surgery, a revolutionary approach merging cancer removal with cosmetic preservation.

A 'world-first' cervical implant from Zavation Medical Products combines two materials to enhance bone growth while maintaining critical imaging capabilities.

A new health tech firm says its unified platform can fix patient confusion and provider burnout. But in a crowded market, can one company truly solve it all?

Amid a national organ shortage, a Virginia organization's use of new tech and community campaigns led to a 27.5% jump in organs transplanted since 2021.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

Daré Bioscience launches telehealth for DARE to PLAY™, the first evidence-backed topical sildenafil cream designed to address female sexual arousal.

A new walk-in lab with pediatric care opens in The Marketplace at Steamtown, marking a strategic move in retail health and enhancing local convenience.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

Zelluna partners with Medpace for a first-in-human trial of its ZIMA-101 TCR-NK therapy, a new 'off-the-shelf' approach for hard-to-treat solid tumors.

A new book offers a critical roadmap for medical device developers facing a storm of new AI regulations, complex FDA rules, and evolving IP law.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

With a fresh $118M in funding, Garner Health's AI platform aims to cut healthcare costs by guiding millions of patients to top-rated doctors.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A new company aims to solve why patients stop neurological treatments, focusing on the critical, unsupported time between doctor appointments.